These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17564140)

  • 1. Harm reduction the key to managing problem drug users.
    Flannery W; Farrell M
    Practitioner; 2007 May; 251(1694):99, 101-6. PubMed ID: 17564140
    [No Abstract]   [Full Text] [Related]  

  • 2. The detection of illicit drugs in oral fluid: another potential strategy to reduce illicit drug-related harm.
    Dyer KR; Wilkinson C
    Drug Alcohol Rev; 2008 Jan; 27(1):99-107. PubMed ID: 18034388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach for treating methadone patients created.
    Hosp Peer Rev; 2008 Jul; 33(7):98-100. PubMed ID: 19035035
    [No Abstract]   [Full Text] [Related]  

  • 4. Methadone treatment: common questions, a common answer.
    Newman RG
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():4-5. PubMed ID: 11965091
    [No Abstract]   [Full Text] [Related]  

  • 5. Methadone, morphine and PTSD.
    Macleod AD; Duffy SG
    Aust N Z J Psychiatry; 2002 Dec; 36(6):816-7. PubMed ID: 12406127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methadone as a substitution treatment].
    Paris P
    Rev Infirm; 1995 Oct; (15):55-60. PubMed ID: 8920441
    [No Abstract]   [Full Text] [Related]  

  • 7. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm minimization strategies: opinions of health professionals in rural and remote Australia.
    Peterson GM; Northeast S; Jackson SL; Fitzmaurice KD
    J Clin Pharm Ther; 2007 Oct; 32(5):497-504. PubMed ID: 17875117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The making of the chronic addict.
    Järvinen M; Andersen D
    Subst Use Misuse; 2009; 44(6):865-85. PubMed ID: 19444727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconsider treatment agreements and drug testing.
    Collen M
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):177. PubMed ID: 24784785
    [No Abstract]   [Full Text] [Related]  

  • 12. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
    Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
    Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol and drug dependence: diagnosis and management.
    Sacks TL; Keks NA
    Med J Aust; 1998 Apr; 168(7):355-60. PubMed ID: 9577448
    [No Abstract]   [Full Text] [Related]  

  • 16. Is my patient drug-seeking or in need of pain relief?
    Arnstein P
    Nursing; 2010 May; 40(5):60-1. PubMed ID: 20386408
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches to methadone treatment: harm reduction in theory and practice.
    Järvinen M
    Sociol Health Illn; 2008 Nov; 30(7):975-91. PubMed ID: 18564977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance therapy and chronic pain.
    Streltzer J; Kosten TR
    JAMA; 2003 Nov; 290(18):2403; author reply 2403-4. PubMed ID: 14612466
    [No Abstract]   [Full Text] [Related]  

  • 19. Buprenorphine injection in Melbourne, Australia--an update.
    Aitken CK; Higgs PG; Hellard ME
    Drug Alcohol Rev; 2008 Mar; 27(2):197-9. PubMed ID: 18264882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of pharmacies in the care of drug users: what has changed in ten years. The case of a Swiss region.
    Samitca S; Huissoud T; Jeannin A; Dubois-Arber F
    Eur Addict Res; 2007; 13(1):50-6. PubMed ID: 17172779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.